Abstract
Background
Accumulating evidence indicates associations between ambient air pollution and Kawasaki disease (KD), but the results remain inconsistent.
Objectives
This systematic review and meta-analysis aimed to comprehensively summarize the current evidence on the effects of ambient air pollutants on KD.
Methods
The PubMed, Web of Science, Embase, and Scopus databases were searched up to January 18, 2025 for studies investigating the effects of ambient air pollution on KD. A fixed- or random-effects model was used to calculate pooled ORs with 95% CIs for an increase in ambient air pollutant concentration of 10 μg/m3. The risk of bias was assessed using the Risk of Bias In Nonrandomized Studies of Exposures tool, and the quality of evidence was assessed by the Grading of Recommendations, Assessment, Development, and Evaluations framework. The protocol was registered with PROSPERO (CRD42024545321).
Results
Thirteen studies with 124,857 participants were included. Seven studies were at high risk of bias. The meta-analysis revealed an increased risk of KD after short-term postnatal exposure to PM2.5 (OR: 1.011; 95% CI: 1.003-1.019; I2 = 0%; high-quality evidence) and PM10 (OR: 1.004; 95% CI: 1.000-1.008; I2 = 38%; high-quality evidence), as well as long-term postnatal exposure to PM2.5 (OR: 1.415; 95% CI: 1.179-1.697; I2 = 41%; high-quality evidence). Prenatal exposure to carbon monoxide, nitric oxide, nitrogen oxides, and sulfur dioxide; short-term postnatal exposure to nitric oxide; and long-term postnatal exposure to carbon monoxide and nitrogen oxides were also associated with KD occurrence.
Conclusions
Both prenatal and postnatal exposure to several ambient pollutants are associated with the risk of KD.
Key words: air pollution, child health, Kawasaki disease, meta-analysis, systematic review
Central Illustration
Kawasaki disease (KD) is a systemic vasculitis that affects mainly children and has been reported across all ethnicities spanning all continents, with the highest rates in East Asia.1,2 Despite the availability of effective treatments, KD still poses a great risk for coronary artery and myocardial inflammatory injury because of either delayed treatment or aggressiveness of the disease.3, 4, 5 KD is the most common cause of acquired heart disease in children in high-income regions and is associated with a higher risk for cardiovascular events in adulthood, leading to public health concerns.6, 7, 8, 9, 10 The causes of KD are not completely understood, most likely resulting from the interplay between genetic susceptibility and environmental triggers, involving mechanisms related to immune cell activation, exaggerated inflammatory response, and increased oxidative stress.11, 12, 13, 14, 15
Air pollution has become a major contributor to the global disease burden, leading to 8.1 million deaths in 2021, including 709,000 deaths in children under 5 years of age.16,17 Emerging studies have indicated that exposure to high levels of ambient air pollutants is associated with immune-mediated inflammatory diseases and cardiovascular diseases by triggering innate and adaptive immune responses, inducing inflammation, stimulating oxidative stress, and mediating genetic and epigenetic mechanisms.18, 19, 20, 21, 22, 23 The geographical clustering and seasonal variation of KD incidence and the multiple overlapping mechanisms of KD and air pollutants link KD with environmental factors, including ambient air pollution.24,25
Owing to a range of biological and behavioral factors, the fetuses, infants, and children are uniquely susceptible to the detrimental effects of ambient air pollution.26,27 Importantly, comprehensive interventions targeting modifiable environmental risk factors in early life are crucial for cardiovascular conditions across the lifespan.28 In these circumstances, exploring the associations between prenatal and postnatal exposure to ambient air pollution and KD is of potential public health significance.
Although the associations between ambient air pollution and KD have been investigated in recent years, the results have been inconsistent. For example, a study in Korea reported that exposure to PM2.5 (particulate matter with an aerodynamic diameter ≤2.5 μm) was significantly positively associated with the risk of KD,29 whereas a study in 7 metropolitan regions of North America did not yield this result.30 Zhu et al31 indicated an increased risk of KD onset after ozone (O3) exposure, while Kwon et al32 did not observe this association.
Consequently, we conducted this systematic review and meta-analysis of population-based epidemiological studies to investigate the relationship between exposure to ambient air pollutants in pregnant women and children and the occurrence of KD in children.
Methods
This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 statement (Supplemental Table 1).33 The review protocol was preregistered in PROSPERO (CRD42024545321).
Data sources and search strategy
Four electronic databases (PubMed, Web of Science, Embase, and Scopus) were searched from inception to 11 May 2024 (initial search) and 18 January 2025 (final search) for relevant studies investigating the risk of KD after exposure to ambient air pollution. No limitations were placed on publication year or language. We used the following search terms: air pollution, air pollutants, particulate matter (PM2.5, PM10, suspended particulate matter [SPM], fine particulate matter, fine particles, quasi-ultrafine, ultrafine particles), carbon monoxide (CO), nitric oxide (NO), nitrogen dioxide (NO2), nitrogen oxides (NOX), sulfur dioxide (SO2), O3, black carbon, wildfire, mucocutaneous lymph node syndrome, Kawasaki syndrome, and KD. Manually searching the references of the retained studies was utilized to avoid potentially missed studies in the database searches. Further details of the search strategy are provided in Supplemental Table 2.
Study selection criteria
The PECOS framework (Participants, Exposure, Comparator, Outcome, and Study) was used to formulate the eligibility criteria. Our study participants were pregnant women and children (birth to 19 years). Exposure indicated exposure to ambient (outdoor) air pollutants of anthropogenic or biogenic sources, with metrics established over a certain time period. Exposure during pregnancy was considered prenatal exposure, and exposure between birth and 19 years of age was considered postnatal exposure. Further, we defined short-term postnatal exposure as <1 month and long-term postnatal exposure as ≥1 month.34 Any comparison was included. The investigation outcomes were hospitalization or incidence or prevalence of KD. The diagnosis of KD was performed according to International Classification of Diseases-9, International Classification of Diseases-10, American Heart Association criteria, Japan Kawasaki Disease Research Committee criteria, or clinical diagnosis by physicians. Any type of population-based epidemiological study, including case-crossover, time series, and cohort studies, met the criteria for this study. The detailed inclusion and exclusion criteria are presented in Supplemental Table 3.
After removing duplicates, 2 authors (P.Y. and J.Z.) independently screened studies via 2 phases: 1) all titles and abstracts screening and 2) full-text screening for studies that passed the first screening. Disagreements were resolved through discussion or by consultation with a third author (K.Z.).
Data extraction
Two authors (P.Y. and J.Z.) extracted the information from all eligible studies. The data extracted from the studies included: 1) citation details (first author, publication year, and study period); 2) study design details (geographical location, type of study design, age, male ratio, and sample size); 3) exposure details (exposure assessment method, type of air pollutant, air pollutant level, units of increment, and exposure duration); 4) outcome details (KD), association effect estimates with 95% CIs, outcome types (hospitalization, incidence, or prevalence), and the number of cases; and 5) adjusted covariates (eg, age, sex, and socioeconomic status variables). Disagreements were resolved by discussion until a consensus was reached, and if necessary, a third author (K.Z.) was consulted.
Risk of bias assessment
Two authors (P.Y. and J.Z.) assessed the risk of bias via the Risk of Bias In Nonrandomized Studies of Exposures (ROBINS-E) tool.35 The ROBINS-E consists of 7 domains: 1) bias due to confounding; 2) bias in the selection of participants into the study; 3) bias in exposure classification; 4) bias in departure from intended exposure; 5) bias due to missing data; 6) bias in outcome measurement; and 7) bias in the selection of reported results (Supplemental Table 4). Each domain was rated as low risk of bias, moderate risk of bias, or high risk of bias. The overall risk of bias was recorded as the highest risk of bias in any domain for each study.
Data standardization and synthesis methods
We assumed a linear relationship between each ambient air pollutant and KD and utilized the OR as the effect estimate to evaluate the relationship. Given that the incidence of KD caused by ambient air pollutants is relatively low, the relative risk was considered approximately equal to the OR.36 For studies reporting percentage changes in prevalence, the percentage change was divided by 100 and then increased by 1 to obtain the OR. For studies that reported a regression coefficient (β, ie, natural log relative risk), the regression coefficient was exponentiated to obtain the OR.37
For different lag structures in short-term postnatal exposure, the results for the lag days that were the focus of the study or yielded the largest effect estimate were selected, as no reliable evidence indicated how to choose the optimal lag day. For multiple time points in long-term postnatal exposure, the results for the longest time point were selected. For the single- and multiple-pollutant models, the results of the single-pollutant model were selected. For studies reporting results of the non-COVID-19 and COVID-19 periods, the results of the non-COVID-19 period were selected. For the unadjusted and adjusted models, the results of the final adjusted model were selected. For studies reporting data from industrial and nonindustrial areas, only the risk outcome values of industrial areas were selected for analysis because industrial areas may be associated with higher exposure levels and disease risks.
To facilitate comparisons across studies, we converted the effect estimate of each ambient air pollutant to concentration increments of 10 μg/m3. Conversions from other units to μg/m3 were conducted via the following formula: 1 ppb CO = 1.145 μg/m3; 1 ppm CO = 1,145 μg/m3; 1 ppb NO = 1.23 μg/m3; 1 ppb NO2 = 1.88 μg/m3; 1 ppb NOX = 1.9125 μg/m3; 1 ppb SO2 = 2.62 μg/m3; and 1 ppb O3 = 1.96 μg/m3. We subsequently recalculated the standardized OR and 95% CI (the conversion of the CI was similar to that of the OR) for each ambient air pollutant in each study via the following formulation: OR (standardized) = OR (original)Increment (10)/Increment (original).38
Statistical analysis
Meta-analyses were conducted if at least 3 included studies explored the association between the same pollutant and KD. Data were pooled via the fixed-effect model (inverse variance method) or the random-effect model (DerSimonian‒Laird method with Hartung‒Knapp adjustment) according to whether significant heterogeneity existed.39 The heterogeneity was quantitatively evaluated via the Cochran's Q-test and I2 statistic, with a P value for the Q test <0.1 or I2 >50% considered significant heterogeneity.40 For meta-analyses with significant heterogeneity, subgroup analysis (study design, country development, percentage of males, and population size) was conducted to explore the possible sources of heterogeneity. To investigate the robustness of the results, sensitivity analysis was performed on all results that included at least 3 studies by sequentially removing each study. Publication bias was also assessed for analyses of 3 or more included studies by Egger's test and Begg's test.41,42 The trim and filling method was applied if the P value of Begg's and Egger's tests was <0.05.43
All analyses were conducted using R software (version 4.2.3) with the “meta” package.
Quality assessment
The Newcastle Ottawa Scale (NOS) and the modified NOS were used to assess the quality of the included studies. Specifically, the NOS used for cohort studies measures 3 dimensions: selection (4 items, 1 star per item), comparability (1 item, up to 2 stars), and outcome (3 items, 1 star per item). A study with a NOS score of 1 to 3, 4 to 6, or 7 to 9 was considered poor, intermediate, or high quality, respectively.44 The modified NOS used for case-crossover and time-series studies measures 3 domains: quality of pollutant (0-1 point), quality of outcome (0-1 point), and degree of adjustment for confounding (0-3 points). A study with a modified NOS score of 0 to 1, 2 to 3, or 4 to 5 was considered poor, intermediate, or high quality, respectively.45
The Grading of Recommendations, Assessment, Development, and Evaluations approach was used to evaluate the quality of evidence for each pair of exposure outcomes.46 The quality of evidence was rated as high, moderate, low, or very low by evaluating 8 domains (risk of bias, inconsistency, imprecision, indirectness, publication bias, dose‒response trend, the magnitude of associations, and residual confounding). The details of the Grading of Recommendations, Assessment, Development, and Evaluations assessment are provided in Supplemental Methods 1.
Results
Study selection and study characteristics
A total of 350 studies were identified across the 3 different databases (Figure 1). We removed 181 duplicates, 148 studies by judging the titles and abstracts, and 8 studies through full-text screening (Supplemental Table 5), leaving 13 studies for inclusion.29, 30, 31, 32,34,47, 48, 49, 50, 51, 52, 53, 54
Figure 1.
PRISMA Flow Diagram of Study Screening and Selection
PRISMA = Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
The characteristics of the included studies are presented in Table 1. The majority originated from East Asia (n = 11), and the most common study design was case-crossover (n = 5). One study evaluated prenatal exposure only, 10 studies assessed postnatal exposure only, and 2 studies investigated both prenatal and postnatal exposure. The age range across the studies was 1 month to 18.8 years. The air pollutant concentrations ranged from 0.190 to 49.090 μg/m3 for PM2.5, 47.990 to 92.900 μg/m3 for PM10, 20.000 to 20.100 μg/m3 for SPM, 572.500 to 858.750 μg/m3 for CO, 3.038 to 7.724 μg/m3 for NO, 1.140 to 62.300 μg/m3 for NO2, 46.799 to 48.138 μg/m3 for NOX, 2.280 to 46.000 μg/m3 for SO2, and 56.036 to 87.200 μg/m3 for O3.
Table 1.
Study Characteristics of the Included Studies
| Study |
Exposure |
Exposure |
Outcome |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| First Author (Year) | Location | Design | Time Period | Events | Age | Male (%) | Air Pollutants | Mean Concentration (μg/m3) | Assessment Method | Duration | Outcome | Evidence | Covariates Adjusted |
| Jung (2017) | Taiwan, China | Case-crossover | 2000-2010 | 695 | 2.54 ± 1.21 y | 56.8 | PM10 | 57.390 | Monitoring stations | Short-term after birth | KD admission | ICD-9-CM code 446.1 | Temperature, humidity, northward wind, eastward wind |
| CO | 858.750 | ||||||||||||
| NO2 | 43.616 | ||||||||||||
| SO2 | 11.607 | ||||||||||||
| O3 | 83.790 | ||||||||||||
| Kwon (2022) | Korea | Case-crossover | 2007-2019 | 51,486 | Under 5 y | 58.2 | PM2.5 | 25.040 | Monitoring stations | Short-term after birth | KD admission and IVIG treatment | ICD-10 code M30.3 | Temperature and humidity |
| PM10 | 47.990 | ||||||||||||
| CO | 732.800 | ||||||||||||
| NO2 | 49.519 | ||||||||||||
| SO2 | 12.890 | ||||||||||||
| O3 | 73.304 | ||||||||||||
| Lin (2017) | Shanghai, China | Time series | 2001-2010 | 2,344 | 2.35 y (1 mo to 18.8 y) | 69.5 | PM10 | 92.900 | Monitoring stations | Short-term after birth | KD admission | Japanese/AHA diagnostic criteriaa,b | Temperature, humidity, and long-term and inherent seasonal trends in KD incidence |
| NO2 | 62.300 | ||||||||||||
| SO2 | 46.000 | ||||||||||||
| Buteau (2020) | Quebec, Canada | Cohort | From birth (2006-2012) until March 31, 2018 | 539 | 3 y (0.1-10.4 y) | 60.1 | PM2.5 | 0.190 | Satellite, land-use regression models, and dispersion models | Prenatal | KD admission | ICD-10 code M30.3 | Maternal age, parity, sex, multiple birth, maternal smoking during pregnancy, material deprivation, birth year, and rural/urban residence |
| NO2 | 1.140 | ||||||||||||
| SO2 | 2.280 | ||||||||||||
| Kim (2024) | Korean | Cohort | 2002-2019 | 1,220 | Under 5 y | 58.4 | PM2.5 | 27.400 | Prediction data developed by AiMS-CREATE network | Long-term after birth | KD admission and IVIG treatment | ICD-10 code M30.3 | Age, sex, income status of each individual, and community-level socioeconomic indicators, spatial and temporal trends |
| Yorifuji (2024) | Japan | Cohort | Prenatal: 08/2009-04/2010; Postnatal: 01/2011-12/2012 | 193 | 6-30 mo | 57.0 | Prenatal: SPM | 20.100 | Monitoring stations | Prenatal and long-term after birth | KD admission | Japanese diagnostic criteriaa | Children's (sex, singleton birth, parity, breastfeeding status, daycare attendance), maternal (age, smoking status, education) characteristics, residential area, and per capita taxable income |
| Postnatal: SPM | 20.000 | ||||||||||||
| Oh (2021) | Seoul, Gyeonggi, and Incheon, South Korea | Case-crossover | 2006-2016 | 771 | Under 10 y | 59.4 | PM2.5 | 34.130 | Ground and phase observations and CMAQ modeling data | Short-term after birth | KD admission | ICD-10 code M30.3 | Temperature and humidity |
| Zeft (2016) | USA and Canada | Case-crossover | 1990-2011 | 3,099 | NA | NA | PM2.5 | 7.000-17.200 | Monitoring stations | Short-term after birth | Diagnosed at KD registries | AHA diagnostic criteriab | Temperature and dew point data |
| Kuo (2022) | Taiwan, China | Cohort | 2004-2010 | 4,192 | Under 6 y | 62.0 | Prenatal: | Monitoring stations | Prenatal and long-term after birth | KD admission and IVIG treatment | ICD-9-CM code 446.1 | Age, gender, birth weight, mother age, mode of delivery, preterm delivery, and maternal comorbidity | |
| CO | 595.400 | ||||||||||||
| NO | 7.724 | ||||||||||||
| NO2 | 35.513 | ||||||||||||
| NOx | 48.138 | ||||||||||||
| O3 | 56.036 | ||||||||||||
| Postnatal: | |||||||||||||
| CO | 572.500 | ||||||||||||
| NO | 7.724 | ||||||||||||
| NO2 | 34.611 | ||||||||||||
| NOx | 46.799 | ||||||||||||
| O3 | 56.291 | ||||||||||||
| Zhu (2024) | East China | Case-crossover | 2013-2020 | 1,808 | 2 y (-5 y) | 62.0 | O3 | 87.200 | Satellite-based model | Short-term after birth | KD admission | ICD-9-CM code 446.1/ICD-10 code M30.3 | Temperature and humidity |
| Si (2023) | Chengdu, China | Time series | 2015-2021 | 3,036 | 2 y (38 d-13 y) | 66.3 | PM2.5 | 49.090 | Monitoring stations | Long-term after birth | KD admission | Cutaneous mucocutaneous lymph node syndrome and IVIG nonresponsive KD | Temperature and humidity |
| Fujii (2020) | Beppu, Japan | Time series | 2011-2018 | 185 | 2.1 y (1 mo-12 y) | 53.5 | NO | 3.200 | Monitoring stations | Short-term after birth | KD admission | AHA diagnostic criteriac | Temperature, humidity, and long-term and inherent seasonal trends in KD incidence |
| NO2 | 14.300 | ||||||||||||
| SO2 | 11.200 | ||||||||||||
| Yoneda (2024) | Japan | Time series | July 2014-December 2019 | 55,289 | Under 5 y | NA | Postnatal: | Monitoring stations | Long-term after birth | KD admission | ICD-10 code M30.3 | Long-term trends, seasonality, day of the week, and offset variable: Log of person-days (based on under-5 population from 2020 Census) to standardize incidence rates | |
| PM2.5 | 11.400 | ||||||||||||
| NO | 3.038 | ||||||||||||
| NO2 | 14.664 | ||||||||||||
| SO2 | 3.327 | ||||||||||||
AHA = American Heart Association; CO = carbon monoxide; ICD = International Classification of Diseases; IVIG = intravenous immunoglobulin; KD = Kawasaki disease; NO = nitric oxide; NO2 = nitrogen dioxide; NOx = nitrogen oxides; O3 = ozone; PM = particulate matter; SO2 = sulfur dioxide; SPM = suspended particulate matter.
The 5th revised edition of diagnostic criteria for KD, issued by the Japan Kawasaki Disease Research Committee - Revision of diagnostic guidelines for kawasaki disease (the 5th revised edition).
The criteria of the 2004 AHA statement - Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association.
The criteria of the 2017 AHA statement - Diagnosis, treatment, and long-term management of Kawasaki Disease: a scientific statement for health professionals from the American Heart Association.
Risk of bias
With the ROBINS-E tool, the risk of bias was rated as low in 1 study,49 moderate in 5 studies,29,32,34,47,51 and high in 7 studies30,31,48,50,52, 53, 54 (Supplemental Table 6). The most common issue is exposure classification, which is caused mainly by exposure evaluation at the area level or the use of the nearest monitoring station data. The details of the risk of bias per analysis are presented in Supplemental Table 7.
Prenatal exposure and KD
Three studies evaluated the association between prenatal exposure to at least 1 air pollutant and the risk of KD. Associations were reported for 8 different air pollutants, including PM2.5, SPM, CO, NO, NO2, NOx, SO2, and O3. Because the number of studies reported for the same air pollutant was insufficient (<3) to support the meta-analysis, only a narrative review was performed. Two associations of NO2 suggested a positive (but not both significant) correlation with KD. Among the 7 individual associations, 4 pollutants (CO, NO, NOx, and SO2) had a statistically significant positive correlation with the risk of KD, 2 pollutants (PM2.5 and SPM) had a nonsignificant positive association with KD, and 1 pollutant (O3) was significantly negatively associated with KD (Table 2).
Table 2.
The Summary of Pooled Effect Sizes
| Pollutant | Number of Studies | Pooled OR (95% CI)a | I2 (%) | Pheter | Pegger | Pbegg |
|---|---|---|---|---|---|---|
| Prenatal exposure | ||||||
| PM2.5 | 1 | 2.150 (0.096-42.653) | NA | NA | NA | NA |
| SPM | 1 | 1.130 (0.790-1.610) | NA | NA | NA | NA |
| CO | 1 | 1.001 (1.000-1.001) | NA | NA | NA | NA |
| NO | 1 | 1.024 (1.016-1.032) | NA | NA | NA | NA |
| NO2 | 2 | 2.189 (0.913-5.246) | NA | NA | NA | NA |
| 1.005 (1.005-1.011) | ||||||
| NOx | 1 | 1.005 (1.005-1.010) | NA | NA | NA | NA |
| SO2 | 1 | 1.489 (1.060-2.052) | NA | NA | NA | NA |
| O3 | 1 | 0.995 (0.990-1.000) | NA | NA | NA | NA |
| Short-term postnatal exposure | ||||||
| PM2.5 | 3 | 1.011 (1.003-1.019) | 0 | 0.97 | 0.353 | 0.296 |
| PM10 | 3 | 1.004 (1.000-1.008) | 38 | 0.20 | 0.203 | 1.000 |
| CO | 2 | 1.000 (0.998-1.003) | NA | NA | NA | NA |
| 1.000 (1.000-1.001) | ||||||
| NO | 1 | 1.472 (1.004-2.155) | NA | NA | NA | NA |
| NO2 | 4 | 1.003 (0.997-1.008) | 46 | 0.14 | 0.701 | 1.000 |
| SO2 | 4 | 1.038 (0.942-1.144) | 58 | 0.07 | 0.213 | 0.308 |
| O3 | 3 | 1.017 (0.965-1.071) | 85 | <0.01 | 0.094 | 1.000 |
| Long-term postnatal exposure | ||||||
| PM2.5 | 3 | 1.415 (1.179-1.697) | 41 | 0.19 | 0.296 | 0.083 |
| SPM | 1 | 1.110 (0.730-1.680) | NA | NA | NA | NA |
| CO | 1 | 1.000 (1.000-1.001) | NA | NA | NA | NA |
| NO | 2 | 1.016 (1.008-1.024) | NA | NA | NA | NA |
| 0.922 (0.781-1.084) | ||||||
| NO2 | 2 | 1.005 (1.000-1.011) | NA | NA | NA | NA |
| 1.054 (0.948-1.170) | ||||||
| NOx | 1 | 1.005 (1.000-1.005) | NA | NA | NA | NA |
| SO2 | 1 | 1.000 (0.856-1.161) | NA | NA | NA | NA |
| O3 | 1 | 1.000 (0.995-1.005) | NA | NA | NA | NA |
CO = carbon monoxide; NA = not applicable; NO = nitric oxide; NO2 = nitrogen dioxide; NOx = nitrogen oxides; O3 = ozone; Pbegg = significance of the Beggs test; Pegger = significance of the Egger's test; Pheter = significance of the heterogeneity test; PM = particulate matter; SO2 = sulfur dioxide; SPM = suspended particulate matter.
The pooled OR (95% CI) was calculated by meta-analysis (number of studies ≥3) or presented by the OR (95% CI) of each study (number of studies <3).
Short-term postnatal exposure and KD
Twenty associations between short-term postnatal exposure to at least 1 air pollutant and KD risk were extracted from 7 studies. The associations were reported for 7 different air pollutants, including PM2.5, PM10, CO, NO, NO2, SO2, and O3. A 10 μg/m3 increase in PM2.5 and PM10 was associated with a 1.100% (OR: 1.011; 95% CI: 1.003-1.019) and 0.400% (OR: 1.004; 95% CI: 1.000-1.008) increased overall risk of KD, respectively. A positive but nonsignificant association was found between exposure to NO2, SO2, or O3 and KD, with a pooled effect size for a 10 μg/m3 increase in exposure of 1.003 (95% CI: 0.997-1.008), 1.038 (95% CI: 0.942-1.144), and 1.017 (95% CI: 0.965-1.071), respectively. Among the 3 associations identified in the systematic literature review only, 1 for NO indicated a significant positive correlation with KD, and 2 for CO indicated a positive (but not both significant) correlation with KD (Figure 2, Table 2).
Figure 2.
Forest Plot of Short-Term Postnatal Air Pollution Exposure and Kawasaki Disease
Pooled OR and 95% CI for meta-analysis. Population size represents the number of KD cases included in each individual study. Square sizes represent the relative weight of the studies. Study specific estimates are scaled to a standard unit change of 10 μg/m3. HK = Hartung–Knapp; KD = Kawasaki disease; NO2 = nitrogen dioxide; O3 = ozone; PM = particulate matter; SO2 = sulfur dioxide.
Long-term postnatal exposure and KD
Five studies reported 12 associations between long-term postnatal exposure and KD. Associations were reported for 8 different air pollutants, including PM2.5, SPM, CO, NO, NO2, NOx, SO2, and O3. We found that a 10 μg/m3 increase in PM2.5 was significantly associated with an increased risk of KD (OR: 1.415; 95% CI: 1.179-1.697). Two articles explored the association between NO and KD, with mixed findings. Two articles observed a positive (but not both significant) association between NO2 and KD. Among the 5 individual associations, long-term postnatal exposure to CO or NOx was significantly positively associated with KD, whereas SPM, SO2, and O3 exposure were not significantly associated with KD. (Figure 3, Table 2).
Figure 3.
Forest Plot of Long-Term Postnatal Particulate Matter With an Aerodynamic Diameter ≤2.5 μm Exposure and Kawasaki Disease
Pooled OR and 95% CI for meta-analysis. Population size represents the number of KD cases included in each individual study. Square sizes represent the relative weight of the studies. Study-specific estimates are scaled to a standard unit change of 10 μg/m3. KD = Kawasaki disease.
Subgroup analyses
The heterogeneity test revealed significant heterogeneity in the included studies for KD risk with short-term SO2 and O3 exposure. Therefore, subgroup analyses were conducted to explore the potential causes of heterogeneity.
Supplemental Table 8 shows the results of the subgroup analyses. For the association between short-term postnatal SO2 exposure and KD risk, adverse effects were significantly greater in the study with smaller population sizes (OR: 1.424; 95% CI: 1.118-1.814). The results for SO2 across subgroups were otherwise comparable. With respect to the association between short-term postnatal O3 exposure and KD risk, significant differences between subgroups were found when studies were stratified by the degree of country development and study population size. Remarkably, the number of studies/effect sizes included in these subgroup analyses was small, implying insufficient statistical power for the tests.
Sensitivity analyses and publication bias
Sensitivity analyses and publication bias evaluations were conducted for short-term postnatal exposure to PM2.5, PM10, NO2, SO2, and O3, as well as for long-term postnatal exposure to PM2.5. Sensitivity analyses demonstrated the general stability of the main results before and after each study was removed. Notably, removing the Kwon study turned the pooled estimate for PM2.5 into nonsignificant, and excluding the Lin study turned the pooled estimate for PM10 into nonsignificant. Additionally, the omission of the Fujii study made the pooled estimate for SO2 significant, and the omission of the Kwon study made the pooled estimate for O3 significant (Supplemental Table 9). Egger's test and Begg's test revealed no statistically significant publication bias for the above analyses (all P > 0.05).
Quality assessment
Based on the NOS score, all cohort studies were classified as high quality (NOS score: 7-9). Using the modified NOS score, 5 case-crossover studies and 3 time-series studies were classified as high quality (modified NOS score: 4), while 1 time-series study was intermediate quality (modified NOS score: 3) (Supplemental Table 10).
The quality of evidence was high for short-term postnatal exposure to PM2.5 and PM10 and long-term postnatal exposure to PM2.5; moderate for short-term postnatal exposure to NO2 and SO2; and low for short-term postnatal O3 exposure. Overall, the lowest-scoring domains were imprecision and inconsistency, whereas the domain that contributed most to the upgrade in evidence quality was the dose‒response trend (Supplemental Table 11).
Discussion
To our knowledge, this is the first systematic review and meta-analysis to comprehensively synthesize the relationship between prenatal and postnatal ambient air pollution exposure and the risk of KD (Central Illustration). We included 13 studies covering 124,857 participants from North America and East Asia. Our meta-analysis revealed significant positive associations between short-term postnatal exposure to PM2.5 and PM10, as well as long-term postnatal exposure to PM2.5, and the risk of KD. Additionally, individual studies have demonstrated that gestational exposure to CO, NO, NOX, and SO2; short-term postnatal exposure to NO; and long-term postnatal exposure to CO and NOX could increase the risk of KD. In contrast, gestational O3 exposure decreased the risk. The probable reason for this is the dose-dependent or threshold effect of prenatal O3 exposure, but the harmful critical value is still unclear.51 Further research is also needed to investigate how O3 affects the development of KD.
Central Illustration.
Prenatal and Postnatal Exposure to Ambient Pollutants Are Associated With Kawasaki Disease
The systematic review and meta-analysis revealed that prenatal and postnatal exposure to several ambient pollutants is associated with an increased risk of KD. The pooled OR (95% CI) was calculated by meta-analysis (number of studies ≥3) or presented by the OR (95% CI) of each study (number of studies <3). CO = carbon monoxide; KD = Kawasaki disease; NO = nitric oxide; NO2 = nitrogen dioxide; NOx = nitrogen oxides; O3 = ozone; PM = particulate matter; SO2 = sulfur dioxide; SPM = suspended particulate matter.
The results of the sensitivity analyses were consistent with the overall results, and all results were not affected by publication bias. To ascertain the sources of heterogeneity, we conducted subgroup analyses stratified by potential factors. The results of subgroup analyses demonstrated that population size appeared to be the source of heterogeneity in the SO2 group, with significantly larger estimates, and the degree of country development and study population size appeared to be sources of heterogeneity among O3 studies, with developing countries and smaller study population sizes being more likely to observe KD. Small sample studies are often inferior to large sample studies but tend to have larger effect sizes.55 Demographic and epidemiological trends and elevated air pollution levels in middle-/lower-income developing countries amplify the impact of ambient air pollution.56
Several potential biological mechanisms underlying the association between ambient air pollution exposure and KD have been suggested. Inflammation, oxidative stress, immune dysregulation, and genetic susceptibility are thought to strongly contribute to KD development.14
Recent studies have reported that exposure to air pollutants during pregnancy can promote inflammation and oxidative stress, inducing placental inflammation, stress, and immunological changes, leading to adverse outcomes in offspring.27,57, 58, 59, 60 Maternal systemic inflammation caused by exposure to ambient air pollutants may affect fetal inflammatory and immune responses. Specifically, gestational exposure to air pollutants can affect cytokine secretion and the lymphocyte immunophenotype distribution and increase the C-reactive protein level in human cord blood.61, 62, 63 Moreover, maternal exposure to pollutants during pregnancy may affect fetal lung development, possibly via oxidative stress, which could elevate children's susceptibility to environmental factors throughout life.64,65 Furthermore, environmental factors, including air pollutants, may trigger epigenetic changes throughout life (which are extremely sensitive during embryogenesis), affecting immune programming and organ development.64,66
Postnatal exposure to ambient air pollutants, both short-term and long-term, also contributes to the development of KD in children. Air pollutants can generate reactive oxygen species by undergoing redox cycling and depleting endogenous thiols, inducing oxidative stress.67,68 Multiple cellular sensing mechanisms triggered by pollution constituents, such as toll-like receptors, Nod-like receptors, aryl hydrocarbon receptors, and reactive oxygen species-sensing pathways, are involved in activating proinflammatory cascades.69,70 Additionally, air pollutants have direct effects on the human immune system, including hyperstimulating innate immunity and affecting adaptive immunity. Air pollutants can stimulate the recruitment and activation of many types of innate immune cells, such as neutrophils and macrophages.20 Moreover, air pollutants can trigger adaptive immunity by enhancing T helper lymphocyte type 2 and 17 responses and can dysregulate antimicrobial immune responses.71 Furthermore, epigenetic DNA methylation, noncoding RNA regulation, and histone modifications play important roles in mediating the effects of air pollution.72 Thus, the hypothesis that exposure to air pollutants can induce oxidative stress, systemic inflammation, immune dysregulation, and epigenetic changes may explain the impact of air pollution on the pathogenesis of KD.
Study strengths and limitations
This is the first comprehensive systematic review of existing epidemiological evidence on ambient air pollution and the risk of KD. We examined a wide spectrum of air pollutants and investigated prenatal and postnatal (both short- and long-term) exposure. We used the Hartung–Knapp approach, which could reduce type I error and provide more robust results, especially when study population sizes differ and the study number is limited.73
Nevertheless, several limitations should be acknowledged. First, most studies focused on short-term postnatal exposure, and research on the effects of prenatal and long-term postnatal exposure was relatively insufficient. More studies on these periods are highly suggested. Second, exposure measurements were inconsistent and not standardized across studies. A considerable proportion rely on distance from monitoring stations, and studies on long-term exposure often fail to consider relocation information, which may lead to certain exposure biases. Studies with improved exposure measurements are needed in the future. Third, we used single-pollutant models instead of multiple-pollutant models because most included studies used single-pollutant models to generate their effect estimates. However, single-pollutant models cannot assess the interactions among air pollutants. Further research using multiple-pollutant models is needed to explore the interactions of concomitant exposure to multiple air pollutants and time-activity patterns. Fourth, the Kwon study contributed the largest weight to our meta-analysis results on short-term postnatal exposure, as further evidenced by the sensitivity analyses. Fifth, although the publication bias tests showed no statistically significant publication bias, the number of studies included for each outcome was below 10 (generally regarded as the minimum threshold for conducting publication bias tests). Sixth, most of the included studies are from Asia. Future research in other regions with high levels of air pollution is needed to increase the generalizability of the findings. Finally, although the included studies adjusted for a range of confounders, confounders differed among these studies, and residual confounders may still be present. These issues limit the interpretability of the findings. Therefore, more detailed consideration of confounders should be taken into consideration.
Ambient air pollution poses a substantial challenge to public health worldwide because it threatens human health, including the probable increased risk of KD. Future studies conducted in other regions with high levels of air pollution investigating prenatal and long-term postnatal exposure and employing standard exposure assessment methods, multiple-pollutant models, and detailed confounders are warranted to provide a complete understanding of the association between air pollution and KD and better risk information to regulatory agencies.
Conclusions
The present systematic review and meta-analysis revealed that prenatal and postnatal exposure to several ambient pollutants are associated with a higher incidence of KD. Appropriate policies and actions are suggested to ameliorate this global public health concern.
Perspectives.
COMPETENCY IN MEDICAL KNOWLEDGE: This systematic review and meta-analysis of 13 epidemiological studies and 124,857 participants revealed that prenatal exposure to CO, NO, NOX, and SO2; short-term postnatal exposure to PM2.5, PM10, and NO; and long-term postnatal exposure to PM2.5, CO, and NOX are associated with an increased risk of KD.
TRANSLATIONAL OUTLOOK: Further studies are necessary to explore the potential biological mechanisms underlying the association of prenatal and postnatal ambient air pollution exposure and KD risk and to evaluate whether air pollution prevention and control interventions can reduce KD incidence.
Funding support and author disclosures
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Footnotes
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.
Appendix
For supplemental tables and methods, please see the online version of this paper.
Supplementary data
References
- 1.Lin M.-T., Wu M.-H. The global epidemiology of Kawasaki disease: review and future perspectives. Glob Cardiol Sci Pract. 2017;2017 doi: 10.21542/gcsp.2017.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Day-Lewis M., Son M.B.F., Lo M.S. Kawasaki disease: contemporary perspectives. Lancet Child Adolesc Health. 2024;8:781–792. doi: 10.1016/S2352-4642(24)00169-X. [DOI] [PubMed] [Google Scholar]
- 3.Kato H., Sugimura T., Akagi T., et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94:1379–1385. doi: 10.1161/01.cir.94.6.1379. [DOI] [PubMed] [Google Scholar]
- 4.Dionne A., Dahdah N. Myocarditis and Kawasaki disease. Int J Rheum Dis. 2018;21:45–49. doi: 10.1111/1756-185X.13219. [DOI] [PubMed] [Google Scholar]
- 5.Dahdah N. Not just coronary arteritis, Kawasaki disease is a myocarditis, too. J Am Coll Cardiol. 2010;55:1507. doi: 10.1016/j.jacc.2009.11.067. author reply 1507-1508. [DOI] [PubMed] [Google Scholar]
- 6.Newburger J.W., Takahashi M., Burns J.C. Kawasaki disease. J Am Coll Cardiol. 2016;67:1738–1749. doi: 10.1016/j.jacc.2015.12.073. [DOI] [PubMed] [Google Scholar]
- 7.Daniels L.B., Roberts S., Moreno E., Tremoulet A.H., Gordon J.B., Burns J.C. Long-term health outcomes in young adults after Kawasaki disease. Int J Cardiol Heart Vasc. 2022;40 doi: 10.1016/j.ijcha.2022.101039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Gordon J.B., Daniels L.B., Kahn A.M., et al. The spectrum of cardiovascular lesions requiring intervention in adults after Kawasaki disease. JACC Cardiovasc Interv. 2016;9:687–696. doi: 10.1016/j.jcin.2015.12.011. [DOI] [PubMed] [Google Scholar]
- 9.Daniels L.B., Tjajadi M.S., Walford H.H., et al. Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia. Circulation. 2012;125:2447–2453. doi: 10.1161/CIRCULATIONAHA.111.082107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Elakabawi K., Lin J., Jiao F., Guo N., Yuan Z. Kawasaki disease: global burden and genetic background. Cardiol Res. 2020;11:9–14. doi: 10.14740/cr993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Burns J.C. The etiologies of Kawasaki disease. J Clin Invest. 2024;134 doi: 10.1172/JCI176938. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Wang H., Shimizu C., Bainto E., et al. Subgroups of children with Kawasaki disease: a data-driven cluster analysis. Lancet Child Adolesc Health. 2023;7:697–707. doi: 10.1016/S2352-4642(23)00166-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Sun S.-N., Zhou Y., Fu X., et al. A pilot study of the differentiated landscape of peripheral blood mononuclear cells from children with incomplete versus complete Kawasaki disease. World J Pediatr. 2024;20:189–200. doi: 10.1007/s12519-023-00752-4. [DOI] [PubMed] [Google Scholar]
- 14.McCrindle B.W., Rowley A.H., Newburger J.W., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American heart association. Circulation. 2017;135:e927–e999. doi: 10.1161/CIR.0000000000000484. [DOI] [PubMed] [Google Scholar]
- 15.Yahata T., Hamaoka K. Oxidative stress and Kawasaki disease: how is oxidative stress involved from the acute stage to the chronic stage? Rheumatology (Oxford) 2017;56:6–13. doi: 10.1093/rheumatology/kew044. [DOI] [PubMed] [Google Scholar]
- 16.GBD 2021 Risk Factors Collaborators Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2162–2203. doi: 10.1016/S0140-6736(24)00933-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.State of global air 2024. https://www.stateofglobalair.org/
- 18.Adami G., Pontalti M., Cattani G., et al. Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study. RMD Open. 2022;8 doi: 10.1136/rmdopen-2021-002055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.de Bont J., Jaganathan S., Dahlquist M., Persson Å., Stafoggia M., Ljungman P. Ambient air pollution and cardiovascular diseases: an umbrella review of systematic reviews and meta-analyses. J Intern Med. 2022;291:779–800. doi: 10.1111/joim.13467. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Skevaki C., Nadeau K.C., Rothenberg M.E., et al. Impact of climate change on immune responses and barrier defense. J Allergy Clin Immunol. 2024;153:1194–1205. doi: 10.1016/j.jaci.2024.01.016. [DOI] [PubMed] [Google Scholar]
- 21.Wu W., Jin Y., Carlsten C. Inflammatory health effects of indoor and outdoor particulate matter. J Allergy Clin Immunol. 2018;141:833–844. doi: 10.1016/j.jaci.2017.12.981. [DOI] [PubMed] [Google Scholar]
- 22.Li Z., Liu Q., Xu Z., Guo X., Wu S. Association between short-term exposure to ambient particulate air pollution and biomarkers of oxidative stress: a meta-analysis. Environ Res. 2020;191 doi: 10.1016/j.envres.2020.110105. [DOI] [PubMed] [Google Scholar]
- 23.Decrue F., Townsend R., Miller M.R., Newby D.E., Reynolds R.M. Ambient air pollution and maternal cardiovascular health in pregnancy. Heart. 2023;109:1586–1593. doi: 10.1136/heartjnl-2022-322259. [DOI] [PubMed] [Google Scholar]
- 24.Rypdal M., Rypdal V., Burney J.A., et al. Clustering and climate associations of Kawasaki Disease in San Diego County suggest environmental triggers. Sci Rep. 2018;8 doi: 10.1038/s41598-018-33124-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Manlhiot C., Mueller B., O'Shea S., et al. Environmental epidemiology of Kawasaki disease: linking disease etiology, pathogenesis and global distribution. PLoS One. 2018;13 doi: 10.1371/journal.pone.0191087. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Kingdon C. Air pollution is the largest environmental risk to public health and children are especially vulnerable. BMJ. 2023;381:1037. doi: 10.1136/bmj.p1037. [DOI] [PubMed] [Google Scholar]
- 27.Brumberg H.L., Karr C.J., COUNCIL ON ENVIRONMENTAL HEALTH Ambient air pollution: health hazards to children. Pediatrics. 2021;147 doi: 10.1542/peds.2021-051484. [DOI] [PubMed] [Google Scholar]
- 28.Zachariah J.P., Jone P.-N., Agbaje A.O., et al. Environmental exposures and pediatric cardiology: a scientific statement from the American Heart Association. Circulation. 2024;149:e1165–e1175. doi: 10.1161/CIR.0000000000001234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Kim H., Jang H., Lee W., et al. Association between long-term PM2.5 exposure and risk of Kawasaki disease in children: a nationwide longitudinal cohort study. Environ Res. 2024;244 doi: 10.1016/j.envres.2023.117823. [DOI] [PubMed] [Google Scholar]
- 30.Zeft A.S., Burns J.C., Yeung R.S., et al. Kawasaki disease and exposure to fine particulate air pollution. J Pediatr. 2016;177:179–183.e1. doi: 10.1016/j.jpeds.2016.06.061. [DOI] [PubMed] [Google Scholar]
- 31.Zhu Y., Chen R., Liu C., et al. Short-term exposure to ozone may trigger the onset of Kawasaki disease: an individual-level, case-crossover study in East China. Chemosphere. 2024;349 doi: 10.1016/j.chemosphere.2023.140828. [DOI] [PubMed] [Google Scholar]
- 32.Kwon D., Choe Y.J., Kim S.-Y., Chun B.C., Choe S.-A. Ambient air pollution and kawasaki disease in Korean children: a study of the national health insurance claim data. J Am Heart Assoc. 2022;11 doi: 10.1161/JAHA.121.024092. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Page M.J., McKenzie J.E., Bossuyt P.M., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10:89. doi: 10.1186/s13643-021-01626-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Yorifuji T., Tsukahara H., Kashima S., Doi H. Intrauterine and early postnatal exposure to particulate air pollution and kawasaki disease: a nationwide longitudinal survey in Japan. J Pediatr. 2018;193:147–154.e2. doi: 10.1016/j.jpeds.2017.10.012. [DOI] [PubMed] [Google Scholar]
- 35.ROBINS-E Development Group Risk of bias tools - ROBINS-E tool. https://www.riskofbias.info/welcome/robins-e-tool
- 36.Greenland S., Thomas D.C. On the need for the rare disease assumption in case-control studies. Am J Epidemiol. 1982;116:547–553. doi: 10.1093/oxfordjournals.aje.a113439. [DOI] [PubMed] [Google Scholar]
- 37.Borroni E., Pesatori A.C., Bollati V., Buoli M., Carugno M. Air pollution exposure and depression: a comprehensive updated systematic review and meta-analysis. Environ Pollut. 2022;292 doi: 10.1016/j.envpol.2021.118245. [DOI] [PubMed] [Google Scholar]
- 38.Shah A.S.V., Langrish J.P., Nair H., et al. Global association of air pollution and heart failure: a systematic review and meta-analysis. Lancet. 2013;382:1039–1048. doi: 10.1016/S0140-6736(13)60898-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Röver C., Knapp G., Friede T. Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies. BMC Med Res Methodol. 2015;15:99. doi: 10.1186/s12874-015-0091-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Higgins J.P.T., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560. doi: 10.1136/bmj.327.7414.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634. doi: 10.1136/bmj.315.7109.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–1101. [PubMed] [Google Scholar]
- 43.Duval S., Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455–463. doi: 10.1111/j.0006-341x.2000.00455.x. [DOI] [PubMed] [Google Scholar]
- 44.NOS. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
- 45.Fonderson M.S., van Meel E.R., Bindels P., Bohnen A., Burdorf A., de Schepper E. Air pollution and childhood respiratory consultations in primary care: a systematic review. Arch Dis Child. 2024;109:297–303. doi: 10.1136/archdischild-2023-326368. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Guyatt G., Oxman A.D., Akl E.A., et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383–394. doi: 10.1016/j.jclinepi.2010.04.026. [DOI] [PubMed] [Google Scholar]
- 47.Jung C.-R., Chen W.-T., Lin Y.-T., Hwang B.-F. Ambient air pollutant exposures and hospitalization for Kawasaki disease in Taiwan: a case-crossover study (2000-2010) Environ Health Perspect. 2017;125:670–676. doi: 10.1289/EHP137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Lin Z., Meng X., Chen R., et al. Ambient air pollution, temperature and Kawasaki disease in Shanghai, China. Chemosphere. 2017;186:817–822. doi: 10.1016/j.chemosphere.2017.08.054. [DOI] [PubMed] [Google Scholar]
- 49.Buteau S., Belkaibech S., Bilodeau-Bertrand M., Hatzopoulou M., Smargiassi A., Auger N. Association between Kawasaki disease and prenatal exposure to ambient and industrial air pollution: a population-based cohort study. Environ Health Perspect. 2020;128 doi: 10.1289/EHP6920. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Oh J., Lee J.H., Kim E., Kim S., Kim H.S., Ha E. Is short-term exposure to PM2.5 relevant to childhood kawasaki disease? Int J Environ Res Public Health. 2021;18:924. doi: 10.3390/ijerph18030924. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Kuo N.-C., Lin C.-H., Lin M.-C. Prenatal and early life exposure to air pollution and the incidence of Kawasaki disease. Sci Rep. 2022;12:3415. doi: 10.1038/s41598-022-07081-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Si F., Zhou C., Yang Y., Huang L. Study of the relationship between occurrence of Kawasaki disease and air pollution in Chengdu by parametric and semi-parametric models. Environ Sci Pollut Res Int. 2023;30:117706–117714. doi: 10.1007/s11356-023-30533-5. [DOI] [PubMed] [Google Scholar]
- 53.Fujii F., Egami N., Inoue M., Koga H. Weather condition, air pollutants, and epidemics as factors that potentially influence the development of Kawasaki disease. Sci Total Environ. 2020;741 doi: 10.1016/j.scitotenv.2020.140469. [DOI] [PubMed] [Google Scholar]
- 54.Yoneda K., Shinjo D., Takahashi N., Fushimi K. Spatiotemporal analysis of the association between Kawasaki disease incidence and PM2.5 exposure: a nationwide database study in Japan. BMJ Paediatr Open. 2024;8 doi: 10.1136/bmjpo-2024-002887. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Moher D., Altman D.G., Schulz K.F., Elbourne D.R. Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyond. CMAJ. 2004;171:349–350. doi: 10.1503/cmaj.1040031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Cohen A.J., Brauer M., Burnett R., et al. Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015. Lancet. 2017;389:1907–1918. doi: 10.1016/S0140-6736(17)30505-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Liu Y., Wang L., Wang F., Li C. Effect of fine particulate matter (PM2.5) on rat placenta pathology and perinatal outcomes. Med Sci Monit. 2016;22:3274–3280. doi: 10.12659/MSM.897808. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Yue H., Ji X., Zhang Y., Li G., Sang N. Gestational exposure to PM2.5 impairs vascularization of the placenta. Sci Total Environ. 2019;665:153–161. doi: 10.1016/j.scitotenv.2019.02.101. [DOI] [PubMed] [Google Scholar]
- 59.García-Serna A.M., Hernández-Caselles T., Jiménez-Guerrero P., et al. Air pollution from traffic during pregnancy impairs newborn's cord blood immune cells: the NELA cohort. Environ Res. 2021;198 doi: 10.1016/j.envres.2020.110468. [DOI] [PubMed] [Google Scholar]
- 60.Broséus L., Guilbert A., Hough I., et al. Placental DNA methylation signatures of prenatal air pollution exposure and potential effects on birth outcomes: an analysis of three prospective cohorts. Lancet Planet Health. 2024;8:e297–e308. doi: 10.1016/S2542-5196(24)00045-7. [DOI] [PubMed] [Google Scholar]
- 61.García-Serna A.M., Martín-Orozco E., Jiménez-Guerrero P., et al. Cytokine profiles in cord blood in relation to prenatal traffic-related air pollution: the NELA cohort. Pediatr Allergy Immunol. 2022;33 doi: 10.1111/pai.13732. [DOI] [PubMed] [Google Scholar]
- 62.Hertz-Picciotto I., Herr C.E.W., Yap P.-S., et al. Air pollution and lymphocyte phenotype proportions in cord blood. Environ Health Perspect. 2005;113:1391–1398. doi: 10.1289/ehp.7610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.van den Hooven E.H., de Kluizenaar Y., Pierik F.H., et al. Chronic air pollution exposure during pregnancy and maternal and fetal C-reactive protein levels: the Generation R Study. Environ Health Perspect. 2012;120:746–751. doi: 10.1289/ehp.1104345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Korten I., Ramsey K., Latzin P. Air pollution during pregnancy and lung development in the child. Paediatr Respir Rev. 2017;21:38–46. doi: 10.1016/j.prrv.2016.08.008. [DOI] [PubMed] [Google Scholar]
- 65.Latzin P., Röösli M., Huss A., Kuehni C.E., Frey U. Air pollution during pregnancy and lung function in newborns: a birth cohort study. Eur Respir J. 2009;33:594–603. doi: 10.1183/09031936.00084008. [DOI] [PubMed] [Google Scholar]
- 66.Zhao C.-N., Xu Z., Wu G.-C., et al. Emerging role of air pollution in autoimmune diseases. Autoimmun Rev. 2019;18:607–614. doi: 10.1016/j.autrev.2018.12.010. [DOI] [PubMed] [Google Scholar]
- 67.Lodovici M., Bigagli E. Oxidative stress and air pollution exposure. J Toxicol. 2011;2011 doi: 10.1155/2011/487074. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Gangwar R.S., Bevan G.H., Palanivel R., Das L., Rajagopalan S. Oxidative stress pathways of air pollution mediated toxicity: recent insights. Redox Biol. 2020;34 doi: 10.1016/j.redox.2020.101545. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Muralidharan S., Mandrekar P. Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation. J Leukoc Biol. 2013;94:1167–1184. doi: 10.1189/jlb.0313153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Kampfrath T., Maiseyeu A., Ying Z., et al. Chronic fine particulate matter exposure induces systemic vascular dysfunction via NADPH oxidase and TLR4 pathways. Circ Res. 2011;108:716–726. doi: 10.1161/CIRCRESAHA.110.237560. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Glencross D.A., Ho T.-R., Camiña N., Hawrylowicz C.M., Pfeffer P.E. Air pollution and its effects on the immune system. Free Radic Biol Med. 2020;151:56–68. doi: 10.1016/j.freeradbiomed.2020.01.179. [DOI] [PubMed] [Google Scholar]
- 72.Shukla A., Bunkar N., Kumar R., et al. Air pollution associated epigenetic modifications: transgenerational inheritance and underlying molecular mechanisms. Sci Total Environ. 2019;656:760–777. doi: 10.1016/j.scitotenv.2018.11.381. [DOI] [PubMed] [Google Scholar]
- 73.IntHout J., Ioannidis J.P.A., Borm G.F. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol. 2014;14:25. doi: 10.1186/1471-2288-14-25. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.





